Testing effectiveness (Phase 2)Study completedNCT02227823
What this trial is testing
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
Who this might be right for
Spinal Muscular Atrophy Type 3
Centre Hospitalier Régional de la Citadelle 4